<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>32</volume><submitter>Lim LL</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>In Asia, diabetes-associated death due to cardiorenal diseases were 2-3 times higher in women than men which might be due to gender disparity in quality of care and health habits.&lt;h4>Methods&lt;/h4>Adults with type 2 diabetes (T2D) from 11 Asian countries/areas were assessed using the same protocol (2007-2015). We compared treatment target attainment (HbA&lt;sub>1c&lt;/sub> &lt; 7%, blood pressure [BP] &lt; 130/80 mmHg, risk-based LDL-cholesterol, lack of central obesity [waist circumference &lt;90 cm in men or &lt;80 cm in women), use of cardiorenal-protective drugs (renin-angiotensin system [RAS] inhibitors, statins), and self-reported health habits including self-monitoring blood glucose (SMBG) by gender. Analyses were stratified by countries/areas, age of natural menopause (&lt;50 &lt;i>vs.&lt;/i</pubmed_abstract><journal>The Lancet regional health. Western Pacific</journal><pagination>100663</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9918795</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program.</pubmed_title><pmcid>PMC9918795</pmcid><pubmed_authors>Sobrepena L</pubmed_authors><pubmed_authors>Chia YC</pubmed_authors><pubmed_authors>Thewjitcharoen Y</pubmed_authors><pubmed_authors>Saboo BD</pubmed_authors><pubmed_authors>Lau V</pubmed_authors><pubmed_authors>Yoon KH</pubmed_authors><pubmed_authors>Kesavadev J</pubmed_authors><pubmed_authors>Fu AWC</pubmed_authors><pubmed_authors>Ma RCW</pubmed_authors><pubmed_authors>Goh SY</pubmed_authors><pubmed_authors>Sosale A</pubmed_authors><pubmed_authors>Nguyen TK</pubmed_authors><pubmed_authors>Chow EYK</pubmed_authors><pubmed_authors>Lim LL</pubmed_authors><pubmed_authors>Lau ESH</pubmed_authors><pubmed_authors>Kong APS</pubmed_authors><pubmed_authors>Jia W</pubmed_authors><pubmed_authors>Suwita R</pubmed_authors><pubmed_authors>Chan JCN</pubmed_authors><pubmed_authors>Luk AOY</pubmed_authors><pubmed_authors>Sheu WHH</pubmed_authors><pubmed_authors>Tan ATB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program.</name><description>&lt;h4>Background&lt;/h4>In Asia, diabetes-associated death due to cardiorenal diseases were 2-3 times higher in women than men which might be due to gender disparity in quality of care and health habits.&lt;h4>Methods&lt;/h4>Adults with type 2 diabetes (T2D) from 11 Asian countries/areas were assessed using the same protocol (2007-2015). We compared treatment target attainment (HbA&lt;sub>1c&lt;/sub> &lt; 7%, blood pressure [BP] &lt; 130/80 mmHg, risk-based LDL-cholesterol, lack of central obesity [waist circumference &lt;90 cm in men or &lt;80 cm in women), use of cardiorenal-protective drugs (renin-angiotensin system [RAS] inhibitors, statins), and self-reported health habits including self-monitoring blood glucose (SMBG) by gender. Analyses were stratified by countries/areas, age of natural menopause (&lt;50 &lt;i>vs.&lt;/i</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Mar</publication><modification>2025-04-19T17:49:44.242Z</modification><creation>2025-04-19T17:49:44.242Z</creation></dates><accession>S-EPMC9918795</accession><cross_references><pubmed>36785858</pubmed><doi>10.1016/j.lanwpc.2022.100663</doi></cross_references></HashMap>